Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 60 of 123)
- Relevance
  Sort by

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032

 Report
August 2024
141 Pages
Global

From

€2736EUR$2,999USD£2,338GBP

Genitourinary Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4105EUR$4,500USD£3,509GBP

Antipsychotic Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
January 2025
90 Pages
Global

From

€3500EUR$4,110USD£3,096GBP

Multiple Myeloma Drugs Market Report by Therapy, Drug Type, End-User, Distribution Channel, and Region 2024-2032

 Report
August 2024
138 Pages
Global

From

€2736EUR$2,999USD£2,338GBP

Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
137 Pages
Global

From

€4333EUR$4,750USD£3,704GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Vitiligo Market Report, Forecast by Diseases Type, Treatment Type, End User, Countries and Company Analysis, 2024-2032

 Report
August 2024
250 Pages
Global

From

€2089EUR$2,290USD£1,786GBP

Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
July 2022
521 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032

 Report
August 2024
142 Pages
Global

From

€2736EUR$2,999USD£2,338GBP

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
67 Pages
Global

From

€3193EUR$3,500USD£2,729GBP

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
72 Pages
Global

From

€1824EUR$2,000USD£1,559GBP

Breast Cancer Diagnostic and Drug Technologies: Global Markets

 Report
November 2019
150 Pages
Global

From

€1254EUR$1,375USD£1,072GBP

€2509EUR$2,750USD£2,144GBP

Osteoporosis - Pipeline Review, H2 2020

 Drug Pipelines
October 2020
375 Pages
Global

From

€1824EUR$2,000USD£1,559GBP

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

 Clinical Trials
November 2021
929 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
March 2024
250 Pages
Global

From

€2235EUR$2,450USD£1,910GBP

Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Asia Pacific

From

€4333EUR$4,750USD£3,704GBP

Europe Sodium-dependent Glucose Cotransporter 2 - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Europe

From

€4333EUR$4,750USD£3,704GBP

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
100 Pages
Global

From

€4333EUR$4,750USD£3,704GBP

Multiple Myeloma - Pipeline Insight, 2024

 Clinical Trials
April 2024
230 Pages
Global

From

€2737EUR$3,000USD£2,339GBP

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
February 2022
80 Pages
Global

From

€1824EUR$2,000USD£1,559GBP

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7252EUR$7,950USD£6,199GBP

2,452 Results (Page 60 of 123)
- 1
- 58
- 59
- 60
- 61
- 62

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.